Scale-up of HIV self-testing

the HIV in Europe Steering Committee

Research output: Contribution to journalLetterpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)e72-e74
JournalHIV Medicine
Issue number8
Publication statusPublished - Sep 2018

Bibliographical note

Funding Information:
Funding statement: The HIV in Europe initiative has received project grants from Gilead Sciences, Merck, Pfizer, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, and ViiV Healthcare. The operational procedures within the initiative include the following, to maintain the autonomy of the initiative: the Steering Committee is the governing body on which sponsors have no representation; data, records, reports, intellectual property rights and know-how generated as result of the initiative shall be deemed vested in and the property of the Steering Committee, represented by the Secretariat CHIP Department of Infectious Diseases, Rigshospitalet. CHIP has received funding from the European Union for the INTEGRATE Joint Action, within the framework of the Third Health Programme, and the Danish National Research Foundation (grant number DNRF126). The funders had no role in the decision to publish or preparation of the manuscript.

Cite this